CLL onkowissen
ASO Keyword Dashboard
Tracking 33 keywords for CLL onkowissen in Apple App Store
CLL onkowissen tracks 33 keywords (no keywords rank yet; 33 need traction). Key metrics: opportunity 69.9, difficulty 32.5.
Tracked keywords
33
0 ranked • 33 not ranking yet
Top 10 coverage
—
Best rank — • Latest leader —
Avg opportunity
69.9
Top keyword: links
Avg difficulty
32.5
Lower scores indicate easier wins
Opportunity leaders
- 65.5
links
Opportunity: 73.0 • Difficulty: 45.0 • Rank —
Competitors: 130
- 69.9
login
Opportunity: 72.0 • Difficulty: 43.2 • Rank —
Competitors: 216
- 57.2
um
Opportunity: 72.0 • Difficulty: 38.4 • Rank —
Competitors: 28
- 59.8
die
Opportunity: 72.0 • Difficulty: 36.5 • Rank —
Competitors: 21
- 52.5
im
Opportunity: 71.0 • Difficulty: 31.7 • Rank —
Competitors: 4
Unranked opportunities
links
Opportunity: 73.0 • Difficulty: 45.0 • Competitors: 130
login
Opportunity: 72.0 • Difficulty: 43.2 • Competitors: 216
um
Opportunity: 72.0 • Difficulty: 38.4 • Competitors: 28
die
Opportunity: 72.0 • Difficulty: 36.5 • Competitors: 21
im
Opportunity: 71.0 • Difficulty: 31.7 • Competitors: 4
High competition keywords
user
Total apps: 77,199 • Major competitors: 980
Latest rank: — • Difficulty: 50.3
services
Total apps: 42,291 • Major competitors: 530
Latest rank: — • Difficulty: 48.5
tools
Total apps: 36,501 • Major competitors: 587
Latest rank: — • Difficulty: 47.2
login
Total apps: 15,997 • Major competitors: 216
Latest rank: — • Difficulty: 43.2
links
Total apps: 8,659 • Major competitors: 130
Latest rank: — • Difficulty: 45.0
All tracked keywords
Includes opportunity, difficulty, rankings and competitor benchmarks
| Major Competitors | |||||||
|---|---|---|---|---|---|---|---|
| im | 71 | 100 | 32 | 53 1,440 competing apps Median installs: 300 Avg rating: 4.1 | — | — | 4 major competitor apps |
| services | 69 | 100 | 49 | 77 42,291 competing apps Median installs: 300 Avg rating: 4.0 | — | — | 530 major competitor apps |
| tools | 70 | 100 | 47 | 76 36,501 competing apps Median installs: 500 Avg rating: 4.2 | — | — | 587 major competitor apps |
| user | 67 | 100 | 50 | 81 77,199 competing apps Median installs: 450 Avg rating: 4.0 | — | — | 980 major competitor apps |
| links | 73 | 100 | 45 | 65 8,659 competing apps Median installs: 350 Avg rating: 4.2 | — | — | 130 major competitor apps |
| login | 72 | 100 | 43 | 70 15,997 competing apps Median installs: 450 Avg rating: 4.0 | — | — | 216 major competitor apps |
| sie | 71 | 100 | 32 | 53 1,453 competing apps Median installs: 250 Avg rating: 4.1 | — | — | 0 major competitor apps |
| um | 72 | 100 | 38 | 57 2,741 competing apps Median installs: 650 Avg rating: 4.2 | — | — | 28 major competitor apps |
| ist | 70 | 100 | 31 | 52 1,295 competing apps Median installs: 300 Avg rating: 4.0 | — | — | 0 major competitor apps |
| den | 71 | 100 | 33 | 55 1,952 competing apps Median installs: 250 Avg rating: 4.1 | — | — | 3 major competitor apps |
| mit | 71 | 100 | 33 | 56 2,182 competing apps Median installs: 300 Avg rating: 4.1 | — | — | 1 major competitor apps |
| einen | 70 | 100 | 28 | 47 714 competing apps Median installs: 250 Avg rating: 4.1 | — | — | 0 major competitor apps |
| die | 72 | 100 | 36 | 60 3,952 competing apps Median installs: 350 Avg rating: 4.1 | — | — | 21 major competitor apps |
| auf | 71 | 100 | 32 | 53 1,561 competing apps Median installs: 300 Avg rating: 4.1 | — | — | 0 major competitor apps |
| nur | 69 | 100 | 26 | 43 374 competing apps Median installs: 250 Avg rating: 4.1 | — | — | 0 major competitor apps |
| zu | 71 | 100 | 32 | 53 1,543 competing apps Median installs: 250 Avg rating: 4.1 | — | — | 0 major competitor apps |
| informationen | 69 | 100 | 27 | 46 561 competing apps Median installs: 300 Avg rating: 4.1 | — | — | 0 major competitor apps |
| bietet | 69 | 100 | 25 | 42 356 competing apps Median installs: 300 Avg rating: 4.1 | — | — | 0 major competitor apps |
| als | 70 | 100 | 31 | 51 1,232 competing apps Median installs: 250 Avg rating: 4.0 | — | — | 2 major competitor apps |
| ber | 70 | 100 | 31 | 52 1,296 competing apps Median installs: 300 Avg rating: 4.1 | — | — | 0 major competitor apps |
| der | 71 | 100 | 34 | 57 2,684 competing apps Median installs: 300 Avg rating: 4.1 | — | — | 1 major competitor apps |
| und | 71 | 100 | 34 | 57 2,537 competing apps Median installs: 250 Avg rating: 4.1 | — | — | 1 major competitor apps |
| einem | 69 | 100 | 26 | 43 385 competing apps Median installs: 250 Avg rating: 4.0 | — | — | 0 major competitor apps |
| lt | 68 | 100 | 30 | 40 243 competing apps Median installs: 250 Avg rating: 4.0 | — | — | 3 major competitor apps |
| ig | 69 | 100 | 31 | 43 403 competing apps Median installs: 606 Avg rating: 4.2 | — | — | 8 major competitor apps |
App Description
Die App „onkowissen CLL“ bietet Ihnen einen digitalen, schnellen und einfachen Zugang zu umfangreichen Informationen über Diagnose und Behandlung der chronischen lymphatischen Leukämie (CLL). Die App wurde in Zusammenarbeit mit medizinischen Expertinnen/Experten konzipiert und erstellt und wird regelmäßig aktualisiert sowie weiterentwickelt.
Finden Sie Antworten auf Ihre Fragen zu folgenden Themen:
• Epidemiologie, Pathogenese und Risikofaktoren
• Klinisches Bild und Diagnose inkl. Differenzialdiagnose
• Stadieneinteilung und prognostische Faktoren
• Therapie
• Leitlinienübersicht
• Interaktiver Therapiealgorithmus
• Therapie-/Nebenwirkungsmanagement
• Nachsorge
• Verfügbare Substanzen, inkl.
• Zulassungen
• Wirksamkeitsdaten
• Wirkmechanismen
• Nebenwirkungen
Interaktive Links erlauben einen individuellen und flexiblen Zugang zu den Inhalten, sodass der User seinen Interessen entsprechend navigieren kann.
Die App enthält zusätzlich einen Newsfeed mit Links zu neuen Daten und aktuellen Themen rund um die chronische lymphatische Leukämie. Im Menü Tools und Services finden Sie weitere nützliche Informationen: verwendete Indizes und Scores, Therapieprotokolle, Leitlinien sowie Empfehlungen, inklusive Verlinkungen zu hilfreichen externen Inhalten.
Diese App ist nur für Fachkreise mit einem onkowissen.de-Login bestimmt. Sie dient ausschließlich als Informationsgrundlage für die Behandlung der chronischen lymphatischen Leukämie.